Bright Minds Biosciences (DRUG) Shares Issued (2024 - 2026)

Bright Minds Biosciences' Shares Issued history runs 3 years deep, the most recent figure standing at $266.7 million for Q1 2026.

• Quarterly Shares Issued rose 325.75% year-over-year to $266.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266.7 million (up 325.75% YoY) and the FY2025 annual result came in at $89.6 million, up 244.89% from the prior year.
• Shares Issued was $266.7 million for Q1 2026 at Bright Minds Biosciences, up from $89.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $266.7 million in Q1 2026 and bottomed at $26.0 million in Q3 2024.
• A 3-year average of $111.2 million and a median of $76.1 million in 2025 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2025 — Shares Issued jumped 244.89% — and 2026, when it surged 325.75%.
• Bright Minds Biosciences' Shares Issued stood at $26.0 million in 2024, then soared by 244.89% to $89.6 million in 2025, then soared by 197.83% to $266.7 million in 2026.
• Business Quant data shows DRUG's Shares Issued at $266.7 million in Q1 2026, $89.6 million in Q3 2025, and $62.6 million in Q1 2025.